Your browser doesn't support javascript.
loading
[Revised version of the 4th edition of the WHO classification of malignant lymphomas : What is new?] / Revidierte Fassung der 4. Ausgabe der WHO-Klassifikation maligner Lymphome : Was ist neu?
Ott, G; Klapper, W; Feller, A C; Hansmann, M L; Möller, P; Stein, H; Rosenwald, A; Fend, F.
Afiliação
  • Ott G; Abteilung für Klinische Pathologie, Robert-Bosch-Krankenhaus, und Dr. Margarete Fischer-Bosch-Institut für Klinische Pharmakologie, Auerbachstraße 110/112, 70376, Stuttgart, Deutschland. german.ott@rbk.de.
  • Klapper W; Institut für Pathologie, Sektion Hämatopathologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Deutschland.
  • Feller AC; Hämatopathologie Lübeck, Lübeck, Deutschland.
  • Hansmann ML; Senckenberg Institut für Pathologie, Universitätsklinikum Frankfurt, Frankfurt, Deutschland.
  • Möller P; Institut für Pathologie, Universitätsklinikum Ulm, Ulm, Deutschland.
  • Stein H; Pathodiagnostik Berlin, Berlin, Deutschland.
  • Rosenwald A; Pathologisches Institut und Comprehensive Cancer Center Mainfranken, Universität Würzburg, Würzburg, Deutschland.
  • Fend F; Institut für Pathologie und Neuropathologie, Eberhard-Karls-Universität, Tübingen, Deutschland.
Pathologe ; 40(2): 157-168, 2019 Mar.
Article em De | MEDLINE | ID: mdl-30019203
ABSTRACT
After 8 years, the WHO has now published the updated version of the 4th edition of the classification of hematopoietic and lymphoid tumors. This update provides a conceptual rewrite of existing entities as well as some new provisional entities and categories, particularly among the aggressive B­cell lymphomas. Important new diagnostic categories include the high-grade B­cell lymphomas, the large B­cell lymphoma with IRF4 rearrangement, and the Burkitt-like lymphoma with 11q aberrations. Of particular importance, new concepts concerning the taxonomy and classification of early lymphoid lesions or precursor lesions are included, such as the in situ follicular neoplasia or the in situ mantle cell neoplasia. In addition, the concept of indolent lymphoproliferations, such as breast-implant-associated anaplastic large cell lymphoma and the indolent T­cell lymphoproliferative disorder of the gastrointestinal tract, has been strengthened. Finally, diagnostic criteria for existing lymphoma entities have been refined.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Idioma: De Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Idioma: De Ano de publicação: 2019 Tipo de documento: Article